UPDATED May 07, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$409.34 | 5.1% | 33.3% | US$3.0t | US$476.88 | PE35.3x | E12.7% | 0.7% | Software | ||
AAPL | US$182.40 | 7.1% | 6.2% | US$2.8t | US$204.13 | PE27.9x | E5.9% | 0.5% | Tech | ||
GOOGL | US$171.25 | 5.2% | 59.5% | US$2.1t | US$191.48 | PE25.7x | E12.2% | 0.5% | Media | ||
AMZN | US$188.76 | 7.9% | 77.0% | US$2.0t | US$217.27 | PE52.1x | E21.4% | n/a | Retail | ||
META | US$468.24 | 8.9% | 100.6% | US$1.2t | US$520.45 | PE26x | E12.2% | 0.4% | Media | ||
LLY | US$777.77 | -0.4% | 81.6% | US$700.3b | US$848.35 | PE114.1x | E27.0% | 0.7% | Pharmaceuticals & Biotech | ||
2330 | NT$800.00 | 1.3% | 56.9% | NT$20.7t | NT$912.98 | PE24.2x | E16.1% | 1.8% | Semiconductors | ||
AVGO | US$1,303.11 | 0.2% | 110.7% | US$603.9b | US$1,501.46 | PE52.1x | E23.4% | 1.6% | Semiconductors | ||
NOVO B | kr.882.60 | -2.2% | 54.6% | kr.3.9t | kr.908.65 | PE44.1x | E13.1% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$191.75 | 0.005% | 40.6% | US$550.6b | US$207.83 | PB1.8x | E-1.3% | 2.4% | Banks | ||
WMT | US$60.62 | 2.1% | 18.9% | US$488.6b | US$65.26 | PE31.5x | E10.8% | 1.4% | Consumer Retailing | ||
UNH | US$500.96 | 3.6% | 2.2% | US$460.9b | US$567.36 | PE30x | E19.6% | 1.5% | Healthcare | ||
XOM | US$116.17 | -1.8% | 6.4% | US$458.1b | US$132.62 | PE14x | E2.5% | 3.3% | Energy | ||
700 | HK$365.80 | 5.4% | 11.4% | HK$3.4t | HK$419.63 | PE27.3x | E15.1% | 0.9% | Media | ||
A005930 | ₩81,300.00 | 4.9% | 24.5% | ₩540.4t | ₩103,324.32 | PE28x | E22.8% | 1.8% | Tech | ||
PG | US$165.76 | 1.6% | 7.8% | US$391.2b | US$170.09 | PE26.4x | E7.2% | 2.4% | Household | ||
JNJ | US$148.72 | 2.9% | -7.7% | US$357.9b | US$173.26 | PE21x | E7.0% | 3.3% | Pharmaceuticals & Biotech | ||
COST | US$771.31 | 6.7% | 54.0% | US$342.1b | US$776.52 | PE50.4x | E7.5% | 0.6% | Consumer Retailing | ||
HD | US$340.69 | 1.9% | 17.2% | US$337.6b | US$384.23 | PE22.3x | E4.3% | 2.6% | Retail | ||
MRK | US$130.38 | 0.9% | 11.0% | US$330.2b | US$141.64 | PE143.2x | E24.9% | 2.4% | Pharmaceuticals & Biotech | ||
ORCL | US$117.93 | 3.7% | 22.7% | US$324.1b | US$136.92 | PE30.5x | E14.6% | 1.4% | Software | ||
600519 | CN¥1,770.00 | 3.8% | 2.8% | CN¥2.2t | CN¥2,161.67 | PE28.5x | E12.7% | 2.8% | Food, Beverage & Tobacco | ||
CVX | US$162.67 | 0.9% | 2.2% | US$299.8b | US$183.11 | PE14.8x | E2.5% | 4.0% | Energy | ||
BAC | US$37.84 | 2.2% | 36.8% | US$295.9b | US$40.08 | PB1.1x | E6.2% | 2.5% | Banks |